While one ad is a spoof on the U.S. Immigration and Customs Enforcement (ICE) recruitment efforts with millions of dollars ...

AUSTIN (KXAN) — An affluent Austin commercial real estate broker was arrested on Thursday on accusations he played a key role in growing a high-end cocaine distribution enterprise that catered to ...

Democrats in the House have introduced a new bill that aims to further expand Medicare's ability to negotiate drug prices. The bill, titled the Lowering Drug Costs for American Families Act, would ...

After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with a pharmaceutical ingredient juggernaut in this field. Antheia is teaming ...

URBANA — A federal jury returned eight guilty verdicts on Wednesday against a 49-year-old Danville man. According to a release United States Attorney’s Office, Central District of Illinois, Marcus ...

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor type in patients with non-small cell lung cancer (NSCLC), the FDA has given ...

Pyrukynd, which Agios sells for a rare type of anemia, missed one of its main objectives in a study seen as crucial for its commercial outlook and the company’s reinvention. Uptake for the genetic ...

Nov 17 (Reuters) - Merck (MRK.N), opens new tab said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' (CDTX.O), opens new tab experimental flu drug, and ...

(Reuters) -Merck said on Monday it expects a non-risk adjusted commercial opportunity in excess of $5 billion from Cidara Therapeutics' experimental flu drug. The drugmaker struck a deal worth nearly ...